Fundamental dimension Equity attribute | PGRLeader $228.16▼-0.64% Cap $132.6BP/E 11.5x QuantScore66/100 | AFGPeer $150.62▼-1.85% Cap $12.49BP/E 13.2x QuantScore54/100 | ALLPeer $253.19▼-2.28% Cap $64.02BP/E 5.0x QuantScore61/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
85/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 95/100 | 99/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 52/100 | 43/100 | 52/100 |
Growth Revenue / earnings growth & margins | 49/100 | 10/100 | 39/100 |
Sentiment Analyst ratings, targets & revisions | 43/100 | 32/100 | 27/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 11.5x | 13.2x | 5.0x |
Forward P/E (next FY) | 12.4x | 12.0x | 7.0x |
EV / EBITDA (TTM) | 9.2x | 9.3x | 4.0x |
Price / Sales | 1.4x | 1.5x | 0.9x |
Price / Free Cash Flow | 8.3x | 8.7x | 5.2x |
PEG ratio | 1.29 | 0.51 | 0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 6 / 9 |
Altman Z-Score | 1.32 (Distress) | 0.35 (Distress) | 1.67 (Distress) |
Total debt / equity | 0.24 | 0.38 | 0.22 |
Quick ratio | 0.2x | 0.5x | 0.2x |
Interest coverage | 46.8x | 13.5x | 43.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.3% | -1.9% | +4.6% |
Net income growth YoY | +33.3% | -5.1% | +120.3% |
Gross margin (TTM) | 48.1% | 26.0% | 42.2% |
Operating margin (FY) | 16.2% | 13.2% | 19.8% |
FCF margin (FY) | 19.6% | 17.2% | 14.9% |
5. Trailing price performancePrice change over period |
1M return | +12.8% | +8.8% | +11.5% |
3M return | +6.7% | +4.8% | -2.6% |
6M return | +13.5% | +15.6% | +18.9% |
Year to date | +0.2% | +10.2% | +21.6% |
1Y return | +4.1% | +13.9% | +31.1% |
3Y return | +46.0% | +38.8% | +103.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $355.76 +55.9% upside | $350.62 +132.8% upside | $286.65 +13.2% upside |
Wall Street consensus target | $223.23 -2.2% · range $196.00–$245.00 | $156.00 +3.6% · range $156.00–$156.00 | $266.43 +5.2% · range $221.00–$319.00 |
Consensus stance | 38% Buy52% Hold10% Sell | 41% Buy59% Hold0% Sell | 40% Buy53% Hold7% Sell |